ORIGINAL RESEARCH article
Front. Neurol.
Sec. Applied Neuroimaging
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1589198
This article is part of the Research TopicApplied Neuroimaging for the Diagnosis and Prognosis of Cerebrovascular DiseaseView all 10 articles
Cerebral hemodynamics evaluation of FLAIR vascular hyperintensity in TIA patients with large artery severe stenosis or occlusion
Provisionally accepted- 1Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 2Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China
- 3Deyang Hospital Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Cerebral hemodynamics evaluation of FLAIR vascular hyperintensity in TIA patients with large artery severe stenosis or occlusion Purpose: To assess the practicality and utility of employing dual post-label delay (PLD) arterial spin labeling (ASL) in transient ischemic attack (TIA) individuals exhibiting Fluid-attenuated inversion recovery (FLAIR) vascular hyperintensity (FVH). Materials and methods: We conducted a retrospective review of clinical data from TIA patients presenting with unilateral severe atherosclerotic stenosis or obstruction of either the intracranial internal carotid artery or the middle cerebral artery. Participants were categorized into two groups based on the presence or absence of FVH: FVH positive and FVH negative. All individuals underwent pseudo-continuous ASL perfusion imaging, utilizing distinct PLD durations (1525 ms and 2525 ms) alongside qualitative visual assessments of ASL perfusion irregularities. Standardized TIA evaluations, which included medical history reviews, neuropsychological assessments, and ABCD2 scoring, were performed on all subjects. We explored the correlations between FVHs, clinical manifestations, vascular risk factors, and perfusion metrics. Result: A total of fifty patients were included in this investigation, with FVH detected in 16 subjects (32.0%). The ABCD2 score was notably elevated within the FVH positive cohort compared to the FVH negative group. At a PLD of 1525 ms, cerebral blood flow (CBF) values for the affected and healthy hemispheres in the FVH positive group were recorded at 19.55±6.67 and 40.32±6.83, respectively; corresponding values in the FVH negative group were 23.74±5.03 and 46.43±7.91. For a 2 PLD of 2525 ms, the CBF values for the affected and healthy sides in the FVH positive group were 34.11±5.87 and 50.27±8.57, while the FVH negative group recorded values of 42.79±7.03 and 52.07±7.29, respectively. The differential CBF (ΔCBF) for the affected side in the FVH positive and negative groups was 14.57±4.34 and 19.05±6.10, respectively. A significant negative correlation was established between ΔCBF and ABCD2 scores (Kendall's tau-b=-0.578, p<0.001).The findings of this study indicate a strong association between the presence of FVH signs and a marked reduction in cerebral blood flow, as well as diminished blood flow reserve. This underscores the potential role of FVH as a biomarker for hemodynamic impairment in TIA patients.
Keywords: Arterial Spin Labeling, post label delay, FLAIR vascular hyperintensity, Hyperintense vessel, Magnetic Resonance Imaging
Received: 07 Mar 2025; Accepted: 23 Apr 2025.
Copyright: © 2025 Zeng, Wang, Wang, Yaodan, Liao and Wenbin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Lichuan Zeng, Chengdu University of Traditional Chinese Medicine, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.